Share This Article:

Do All Prostate Cancers Behave the Same?

Abstract Full-Text HTML Download Download as PDF (Size:622KB) PP. 1426-1428
DOI: 10.4236/jct.2013.49169    2,790 Downloads   3,978 Views  

ABSTRACT

Two different immunohistochemical types suggestive of Large Cell Neuroendocrine (NE) carcinoma and Adenocarcinoma in a patient with known diffusely metastatic, hormone refractory prostate carcinoma are rarities. Interestingly, our patient had documented history of exposure to Agent Orange during his time of service. The use of routinely used immunohistochemical stains for pathological diagnosis was a challenge in this case, though throughout his disease course, the diagnosis was confirmed as Adenocarcinoma of prostate with biopsies from all various sites of metastases. Systemic chemotherapy has been historically suboptimal in management of aggressively behaved prostate carcinomas. Finding any association of Agent Orange as a causative etiology and improving diagnosis and management of such aggressive hormone refractory prostate carcinoma need further investigations.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

D. Thusitha, A. Elizabeth and R. Mailien, "Do All Prostate Cancers Behave the Same?," Journal of Cancer Therapy, Vol. 4 No. 9, 2013, pp. 1426-1428. doi: 10.4236/jct.2013.49169.

References

[1] O. Kaufmann and M. Dietel, “Expression of Thyroid Transcription Factor-1 in Pulmonary and Extrapulmonary Small Cell Carcinomas and Other Neuroendocrine Carcinomas of Various Primary Sites,” Histopathology, Vol. 36, No. 5, 2000, pp. 415-420. http://dx.doi.org/10.1046/j.1365-2559. 2000.00890.x
[2] R. Mazzucchelli, D. Morichetti, A. Lopez-Beltran, L. Cheng, M. Scarpelli, Z. Kirkali and R. Montironi, “Neuroendocrine Tumours of the Urinary System and Male Genital Organs: Clinical Significance,” BJU International, Vol. 103, No. 11, 2009, pp. 1465-1470. http://dx.doi.org/10.1111/j.1464-410X. 2009.08451.x
[3] K. Hiroshima, A. Iyoda, T. Shida, K. Shibuya, T. Iizasa, H. Kishi, T. Tanizawa, T. Fujisawa and Y. Nakatani, “Distinction of Pulmonary Large Cell Neuroendocrine Carcinoma from Small Cell Lung Carcinoma: A Morphological, Immunohistochemical, and Molecular Analysis,” Modern Pathology, Vol. 19, No. 10, 2006, pp. 1358-1368. http://dx.doi.org/10.1038/modpathol.3800659
[4] A. J. Evans, P. A. Humphrey, J. Belani, T. H. van der Kwast and J. R. Srigley, “Large Cell Neuroendocrine Carcinoma of Prostate: A Clinicopathologic Summary of 7 Cases of a Rare Manifestation of Advanced Prostate Cancer,” American Journal of Surgical Pathology, Vol. 30, No. 6, 2006, pp. 684-693. http://dx.doi.org/10.1097/00000478-200606000-00003

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.